Table 2. Survival analysis in patients with epithelial ovarian cancer.
|
Overall survival |
|
---|---|---|
Parameters | Univariatea HR (95% CI) | Multivariablea HR (95% CI) |
Tumour stage | ||
FIGO I (reference) | 1 | 1 |
FIGO II | 0.93 (0.35–2.52) | 0.80 (0.26–2.44) |
FIGO III | 5.77 (3.53–9.43) | 2.73 (1.52–4.92) |
FIGO IV |
8.37 (4.87–14.41) |
3.73 (1.92–7.25) |
Histological grade | ||
G1 (reference) | 1 | 1 |
G2 | 4.15 (2.37–7.25) | 2.51 (1.20–5.25) |
G3 |
5.57 (3.24–9.59) |
2.78 (1.32–5.84) |
Residual tumour | ||
(yes vs no) |
3.67 (2.73–4.93) |
2.68 (1.89–3.80) |
Patient's age | ||
(per 10 years) |
1.58 (1.42–1.76) |
1.56 (1.35–1.81) |
GGT | ||
Group A (reference) | 1 | 1 |
Group B | 1.34 (1.00–1.83) | 1.18 (0.82–1.71) |
Group C | 1.11 (0.72–1.69) | 0.90 (0.54–1.49) |
Group D | 2.92 (1.82–4.68) | 3.37 (1.88–6.04) |
Abbreviation: GGT=gamma-glutamyl transferase; FIGO=International Federation of Gynecologists and Obstetricians, HR (95% CI)=hazard ratio (95% confidence interval).
Cox Regression model.